<bill session="115" type="h" number="2022" updated="2019-04-18T16:06:50Z">
  <state datetime="2017-04-06">REFERRED</state>
  <status>
    <introduced datetime="2017-04-06"/>
  </status>
  <introduced datetime="2017-04-06"/>
  <titles>
    <title type="official" as="introduced">To ensure certain safety measures are utilized in the interest of public health security with respect to labeling and transporting human tissue specimen or collection of specimens into interstate commerce.</title>
    <title type="short" as="introduced">Label and Transport Tissues Safely Act of 2017</title>
    <title type="short" as="introduced">Label and Transport Tissues Safely Act of 2017</title>
    <title type="short" as="introduced">LATTS Act of 2017</title>
    <title type="display">LATTS Act of 2017</title>
  </titles>
  <sponsor bioguide_id="G000565"/>
  <cosponsors>
    <cosponsor bioguide_id="G000580" joined="2018-05-01"/>
    <cosponsor bioguide_id="N000190" joined="2018-05-16"/>
    <cosponsor bioguide_id="R000609" joined="2017-05-17"/>
    <cosponsor bioguide_id="S001187" joined="2017-11-08"/>
  </cosponsors>
  <actions>
    <action datetime="2017-04-06">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-04-06" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2017-04-07">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Business records"/>
    <term name="Department of Health and Human Services"/>
    <term name="Fraud offenses and financial crimes"/>
    <term name="Hazardous wastes and toxic substances"/>
    <term name="Health information and medical records"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Licensing and registrations"/>
    <term name="Medical education"/>
    <term name="Medical research"/>
    <term name="Organ and tissue donation and transplantation"/>
    <term name="Product safety and quality"/>
  </subjects>
  <amendments/>
  <summary date="2017-04-06T04:00:00Z" status="Introduced in House">Label and Transport Tissues Safely Act of 2017 or the LATTS Act of 2017 

This bill prohibits the sale of human tissue for research or education unless the seller has a non-transplant tissue bank license, each package of tissue is labeled with specified information, and each package is wrapped in the prescribed manner.

The Department of Health and Human Services (HHS) shall establish a process for the approval, suspension, and revocation of non-transplant tissue bank licenses.

False labeling of packages of human tissue is prohibited.

 HHS or any accrediting body authorized by HHS is allowed to enter and inspect any facility that is subject to a non-transplant tissue bank license.

HHS shall recall any human tissue specimen that is an imminent or substantial hazard to public health.

The bill makes it unlawful to knowingly sell or otherwise transfer any human tissue specimen if the transfer affects interstate commerce.</summary>
  <committee-reports/>
</bill>
